OBJECTIVE: The efficacy and safety were assessed of a @entity396 regimen used alone or in combination with foley catheter for second trimester pregnancy termination. METHODS: A retrospective examination was made of the records of @entity1 who underwent pregnancy termination at 14-24 weeks of gestation in our university hospital between January 2011 and June 2014. Records were available for @entity1 378 who underwent terminations. Group 1 comprised @entity1 with no history of cesarean section. An initial dose of 200  gr @entity396 was administered intravaginally and then until the termination was completed an additional 200   gr dose was administered sublingually every 4 hours (Group 1: 234 @entity1 ). Group 2 comprised @entity1 with a history of cesarean section. An initial dose of 200   gr @entity396 was administered intravaginally and 2 hours later an intracervical foley catheter was inserted (Group 2: 144 @entity1 ). RESULTS: The total @entity396 dosage used was 1160   gr and 560   gr (p< 0.001), intervals from the administration of the first @entity396 tablet until termination were 854.8 and 704.2 minutes (p= 0.03) in Groups 1 and 2 respectively. CONCLUSIONS: The @entity396 + foley catheter combination reduces the total dosage of @entity396 required for termination and shortens the termination interval, thereby increasing @entity1 's comfort. Based on these results, the usage of the @entity396 +foley catheter combination can be recommended especially for @entity1 with a history of caesarian section.

@entity396 versus XXXX and Foley Catheter Combination in 2nd Trimester Pregnancy Terminations.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity396 :: ('MESH:D016595', 'Chemical') :: ['misoprostol']
@entity396 :: (MESH:D016595,Chemical) :: ['Misoprostol']
